Press Releases | MedXCell

MedXCell SA is proud to annonce the arrival of Andrew Galzaka and John D. McMannis as new members of the Board and Pierre J.Magistretti as new scientific advisor

Montreux, Switzerland | March 11, 2022 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

MedXCell SA is pleased to announce the appointment of Dr Jean-Jacques de Dardel as a member of the Board of Directors.

Montreux, Switzerland | August 26, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and accessible new

MedXCell SA has successfully closed a CHF 5.3 million Series A

Montreux, Switzerland | June 4, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

MedXCell SA is proud to announce the arrival of Gabriel Baertschi as a new member of the Board

Montreux, Switzerland | May 17, 2021 – MedXCell SA, a Swiss biotech company dedicated to transforming healthcare through the development and production of affordable and

The MedXCell Group proudly participate in the Med Vallée project of the city of Montpellier, France

Montreux, Switzerland | April 27, 2021 – The MedXCell Group is proud to announce its participation in the Med Vallée project. This European scale project aims

The MedXCell Group is proud to announce the historic entry of the University of Montpellier into the capital of MedXCell Science

Montreux, Switzerland | April 14, 2021 – The MedXCell Group is proud to announce the historic entry of the University of Montpellier (UM) into the